Next Steps If you've been on GLP-1 medications and you're not where you hoped to be or if you're simply curious about whether surgery might be a better fit, a consultation with one of our bariatric surgeons is a good place to start
BPC-157 is dosed in micrograms (typically 250500 mcg per injection), so each 5 mg/5 ml vial covers many more individual doses than a semaglutide vial of the same volume
Research progress Support The animal experiments have achieved remarkable results: In the obese mouse model, after daily subcutaneous injection of AOD 9604 (250 g/kg) for 8 weeks, the body weight of the mice decreased by 12%, the subcutaneous fat mass decreased by 25%, and the weight of epididymal adipose tissue significantly decreased, confirming its effectiveness in fat reduction
Antibodies and Dyes for Flow Cytometry Antibodies were used at manufacturer recommended concentrations and cells were incubated at 4C for 25 mins prior to washing and acquisition: CD3 FITC (BD Biosciences), CD56 PE (BD Biosciences), CD16 PE-Cy7 (ThermoFisher), SLAMF7 PE (BioLegend), and NKG2D APC (ThermoFisher)
Addressing the Lean Mass Problem One of the legitimate concerns about GLP-1 medications is the potential for muscle loss during rapid weight reduction
Serum polyunsaturated fatty acids and endometriosis
